Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy

Y. Gong, R.G.J.K. Wolterink, J.X. Wang, G.M.J. Bos, W.T.V. Germeraad*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Article number73
Number of pages35
JournalJournal of Hematology & Oncology
Issue number1
Publication statusPublished - 1 May 2021


  • Cancer immunotherapy
  • Adoptive cell therapy
  • Chimeric antigen receptor
  • Natural killer cells
  • Genetic modification

Cite this